IDH1 and glioma: To overcome these limitations for our IDH1-mutant gliomas, we performed exome sequencing on PDCs, scPDCs, and PDX samples along with multiple tumor tissue samples and germline normal DNA, for a total of 28 exomes across the 2 patients (Supplementary Table 1).